Question 1

Has Arthur Hillert received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $17,557 in general payments to Arthur Hillert across 275 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Arthur Hillert did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Arthur Hillert come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
Johnson & Johnson	29	$14,415
Novo Nordisk	88	$1,004
Kowa Pharmaceuticals America, Inc.	97	$530
Teva Pharmaceuticals USA, Inc.	7	$293
AstraZeneca	6	$263
Merck	23	$219
Lilly USA, LLC	7	$168
Boehringer Ingelheim	2	$135
Biohaven Pharmaceuticals, Inc.	2	$134
Amgen	2	$128
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	4	$73
Abbott	2	$72
Amarin Pharma, Inc.	3	$51
Kaleo, Inc.	1	$40
Takeda Pharmaceuticals U.S.A., Inc.	1	$21
Antares Pharma, Inc.	1	$12

Arthur Hillert

Payments from drug & device makers

Who reported the general payments

What the payments were tied to

How this compares

Other family medicine in Houston